Nitrefazole
As of the edition of 20 October 2026, Nitrefazole is a small molecule: withdrawn from the market in 1984; acts on ADH1A, ADH1B and ADH1C and 4 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Withdrawn from market, 1984
- Kind
- Small molecule
- Withdrawn from market
- 1 January 1984 (in some regions)
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
| Gene | Protein | UniProt |
|---|---|---|
| ADH1B | All-trans-retinol dehydrogenase [NAD | P00325 |
| ADH1C | Alcohol dehydrogenase 1C | P00326 |
| ADH1A | Alcohol dehydrogenase 1A | P07327 |
| ADH4 | All-trans-retinol dehydrogenase [NAD | P08319 |
| ADH5 | Alcohol dehydrogenase class-3 | P11766 |
| ADH6 | Alcohol dehydrogenase 6 | P28332 |
| ADH7 | All-trans-retinol dehydrogenase [NAD | P40394 |